Skip to main content

Table 6 Presence of symptoms in COVID-19 negative tested patients with olfactory and gustatory dysfunction (binary scaled)

From: Presence of gustatory and olfactory dysfunction in the time of the COVID-19 pandemic

Variable COVID-19 Negative with OGD COVID-19 Negative without OGD p-value
Number of Patients 184 484  
Fever (37.5 °C) 80 (43.48%) 134 (27.69%) 0.0104
Visual Dysfunction 39 (21.20%) 41 (8.47%) 0.0001
Auditory Dysfunction 37 (20.11%) 18 (3.72%) 0.0001
Sensibility Dysfunction 38 (20.65%) 49 (10.12%) 0.0001
Dyspnoea 114 (61.96%) 153 (31.61%) 0.0001
Fatigue 165 (89.67%) 301 (62.19%) 0.0001
Headache 153 (83.15%) 266 (54.96%) 0.0001
Joint Pain 132 (71.74%) 177 (36.57%) 0.0001
Rhinorrhea 132 (71.74%) 220 (45.45%) 0.0001
Cough 139 (75.54%) 239 (49.38%) 0.0001
Pharyngitis 140 (76.09%) 220 (45.45%) 0.0001
Diarrhea 77 (41.85%) 100 (20.66%) 0.0001
Ocular Pruritus 71 (38.59%) 140 (28.93%) 0.0176
Medication
 General use of medication 82 (44.57%) 163 (33.68%) 0.0091
 Ibuprofen 45 (24.46%) 92 (19.01%) 0.1192
 Acetaminophen 31 (16.85%) 59 (12.19%) 0.1152
 Aspirin 9 (4.89%) 16 (3.31%) 0.3348
 Metamizole 12 (6.5%) 9 (1.86%) 0.0020
 Diclofenac 1 (0.54%) 0 0.2754
 Ketoprofen 1 (0.54%) 0 0.2754
 Other medication 11 (5.98%) 18 (3.72%) 0.2005
Pre-existent diseases in COVID-19 negative tested patients with olfactory and gustatory dysfunction (binary scaled)
 Pre-existent disease 109 (59.24%) 322 (66.53%) 0.0314
 Stroke 0 2 (0.41%) 1.0000
 Myocardial Infarction 4 (2.17%) 5 (1.03%) 0.2690
 Chronic heart disease 8 (4.35%) 15 (3.10%) 0.4291
 Rheumatological disease 7 (3.80%) 7 (1.45%) 0.0706
 Transplantation 0 3 (0.62%) 0.5651
 Kidney disease 2 (1.09%) 1 (0.21%) 0.1854
 Dialysis 0 0 n.a
 Autoimmune liver disease 0 1 (0.21%) 1.0000
 Liver cirrhosis 1 (0.54%) 1 (0.21%) 0.4753
 Lung disease 23 (12.50%) 49 (10.12%) 0.3763
 Lupus 0 2 (0.41%) 1.0000
 other 52 (28.26%) 108 (22.31%) 0.1077